Infectious Diseases: Recent Episodes
ReachMD
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Stephen I. Pelton, MD
In the last two pre-pandemic flu seasons, approximately half of hospitalizations from influenza in the US were in adults 65 and older.1,2 A recent real-world study evaluated the relative effectiveness of adjuvanted influenza vaccine versus high-dose vaccine in preventing test-confirmed influenza hospitalizations in this age group across three flu seasons between 2017 and 2020.3 Dr. Charles Turck sits down with Dr. Stephen Pelton, an author on this study, to explore the findings and their implications for influenza vaccination strategies in older adults. Dr. Pelton is a Professor of Pediatrics at the Boston University Chobanian and Avedisian School of Medicine.
References:
- Pelton SI, Nguyen VH, Mould-Quevedo JF. The value of influenza vaccination in the older adult population. A stochastic model estimation of the benefit of vaccination to prevent the severe outcomes in the U.S. Poster presented at: IDWeek 2023; October 11-15; Boston, MA.
- Pelton SI, Mould-Quevedo JF, Nguyen VH. The impact of adjuvanted influenza vaccine on disease severity in the US: a stochastic model. Vaccines. 2023;11:1525.
- McGovern I, Chastek B, Bancroft T, et al. Relative vaccine effectiveness of MF59-adjuvanted vs high-dose trivalent inactivated influenza vaccines for prevention of test-confirmed influenza hospitalizations during the 2017-2020 influenza seasons. Int J Infect Dis. …
Guest: Paul Hunter, MD
The Advisory Committee on Immunization Practices (ACIP) recently updated their recommendations for the 2024-2025 flu season. Here to give us a breakdown of the key updates so we can protect our patients from the flu is family medicine physician Dr. Paul Hunter.
Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Guest: Jill Foster, MD
Guest: John Russell, MD
According to recent studies, co-administering the flu, RSV, and COVID-19 vaccines is generally safe, which is why both the CDC and Advisory Committee on Immunization Practices support this approach. However, there are some important considerations to keep in mind when co-administering these three respiratory vaccines, which is why Dr. Mary Katherine Cheeley speaks with Drs. Jill Foster and John Russell about best practices for co-administration and improving vaccination rates. Dr. Foster is the Director of the Division of Pediatric Infectious Diseases at the University of Minnesota Medical School, and Dr. Russell is a family medicine physician at Jefferson Health System in Abington, Pennsylvania.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: John Russell, MD
According to the CDC, flu vaccine coverage for all adults is about 47 percent, and there’s been a continued decline among pregnant patients and children since 2020. These reduced vaccination rates can have serious consequences for our patients and the healthcare system as a whole, which is why it’s so important for primary care providers to embrace their role in reversing this trend. To help in this mission, Dr. Charles Turck speaks with family medicine physician Dr. John Russell about strategies for boosting flu vaccination rates in the primary care setting.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Darvin Scott Smith, MD
Vaccines play a crucial role in preventing the flu itself, but there are a lot of lesser-known benefits of flu vaccination as well, including its impact on reducing illness severity, hospitalization rates, and co-infections as well as its importance in managing chronic diseases and enhancing public health outcomes. Joining Dr. Charles Turck to examine the comprehensive advantages of flu vaccination is Dr. Darvin Scott Smith, who’s an infectious disease consultant at San Mateo Medical Center in California.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Laila Woc-Colburn, MD, DTM&H, FACP, FIDSA
Since annual flu shots help alleviate the severe disease burden on patients and the healthcare system as a whole, it’s important to make flu vaccination a part of every patient visit. Fortunately, tools like appointment reminders, in-office discussions, and infographics can help us integrate this preventative measure into routine patient care and protect them from the flu. To learn more about these strategies, Dr. Charles Turck speaks with Dr. Laila Woc-Colburn, Associate Professor at the Emory University School of Medicine in Atlanta.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Norman Beatty, MD
Guest: Marvin J. Bittner, MD
Pretravel consultation is essential for a lot of patients with upcoming travel plans so that we can anticipate and mitigate any risks they may encounter. Each conversation is unique to the health aspects of the patient's travel plans. To dive in for best practices when preparing patients for international travel, join Dr. Charles Turck as he speaks with expert panelists, Dr. Norman Beatty, Assistant Professor of Medicine at the University of Florida College of Medicine in the Division of Infectious Diseases and Global Medicine, and Dr. Marvin Bittner, Interim Program Director of the Infectious Diseases Fellowship Program and Special Professor in the Department of Medicine at Creighton University in Omaha, Nebraska.
Valneva did not contribute to the educational content.
Host: Jennifer Caudle, DO
Guest: Michael Barnish, DO
Guest: Norman J. Bizon, PA-C, CTH
Before traveling abroad, it’s important that patients schedule a pre-travel health consultation with their doctor to go over their itinerary and talk about potential risks at their destination. There certainly are patients who are more at risk, such as those with immune-compromising conditions. To learn how to best collaborate with your patients before they travel internationally, dive in with Dr. Jennifer Caudle as she speaks with expert panelists, Dr. Michael Barnish, Infectious Disease Specialist at Rowan Medicine, and Mr. Norman Bizon, Physician Assistant who focuses exclusively on travel medicine at Travel Bug Health.
Valneva did not contribute to the educational content.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: David Hamer, MD
Cases of dengue have more than doubled since 2023, especially in endemic areas like Latin America, the Caribbean, South and Southeast Asia, and the coastal areas of Africa. This increasingly prevalence underscores the importance of knowing how to protect patients traveling abroad to those areas, which is why Dr. Charles Turck speaks with Dr. David Hamer about essential prevention strategies for dengue fever. Dr. Hamer is a Professor of Global Health and Medicine at the Boston University School of Public Health.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: David Hamer, MD
Cases of chikungunya have risen significantly in recent years, but fortunately, there are several ways we can protect our patients traveling abroad, including with a novel vaccine and other anti-mosquito measures. Joining Dr. Charles Tuck to discuss key preventive strategies for the chikungunya virus is Dr. David Hamer, Professor of Global Health and Medicine at the Boston University School of Public Health.
Host: Robert Walker, PharmD
Guest: Nic Garner, PharmD
Travel vaccines are becoming increasingly common as they play a key role in protecting travelers abroad, but they’re only effective if patients actually receive them. That’s why Dr. Robert Walker speaks with Dr. Nic Garner, who shares best practices for counseling patients on travel vaccines. Dr. Garner is the District Support Pharmacist Leader at CVS Pharmacy in Texas with more than 10 years of community pharmacy management experience.
Host: Jody Takemoto, PhD
Guest: Robert Wong, MD
Hepatitis B is one of the leading causes of liver cancer globally, underscoring the importance of screening, diagnosing, and treating patients appropriately. However, there are several considerations to keep in mind when caring for patients with hepatocellular carcinoma with hepatitis B co-infection, which is why Dr. Jody Takemoto speaks with Dr. Robert Wong about those factors and essential management strategies. Dr. Wong is a Clinical Associate Professor of Medicine in the Division of Gastroenterology and Hepatology at Stanford University School of Medicine.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Christina Madison, BS, PharmD, BCACP, AAHIVP
The World Health Organization and the Vaccines and Related Biologics Products Advisory Committee recently recommended transitioning from quadrivalent to trivalent flu vaccines that exclude the B/Yamagata lineage. Explore the epidemiological data that led to this decision and counseling strategies that can help patients understand this new recommendation with Dr. Charles Turck and Dr. Christina Madison, founder and CEO of the Public Health Pharmacist.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Jill Foster, MD
For optimal protection, the best time for patients to receive a flu shot is between September and October, but some patients may be hesitant. In fact, flu vaccination rates have been declining since the onset of the COVID-19 pandemic according to the CDC. That’s why Dr. Charles Turck speaks with Dr. Jill Foster about how we can help ensure patients receive timely and annual flu vaccinations. Dr. Foster is the Director of the Division of Pediatric Infectious Diseases at the University of Minnesota Medical School in Minneapolis.
Guest: Darvin Scott Smith, MD
For optimal protection, the most prevalent flu strains are assessed every year and included in the vaccine. Here to talk about this process and the recent decision to exclude the B/Yamagata lineage from flu vaccines is Dr. Darvin Scott Smith, Infectious Disease and Geographic Medicine Consultant at San Mateo Medical Center in California.
Guest: Ina Park, MD
The United States has seen its largest increase in syphilis cases in the past five years. And with increases prevalent in every region, along with a shortage of medication, additional surveillance strategies and importation resources are necessary. Dive in for a discussion on the challenges and strategies to combat the spread of syphilis with Dr. Ina Park, Professor of Family Community Medicine at the University of California San Francisco School of Medicine.
Host: Matt Birnholz, MD
Guest: Donald Kohn, MD
Third-generation lentiviral vectors were developed to improve upon safety measures and mitigate the risks of toxicity and replication that are typically associated with first- and second-generation therapies. These advancements may help enhance the functionality and utility of third-generation lentiviral vectors in various gene therapy applications. Learn more about the development, efficacy, and safety of third-generation lentiviral vectors with Dr. Matt Birnholz and Dr. Donald Kohn, Distinguished Professor at the University of California, Los Angeles.
This non-certified educational series is produced and controlled by ReachMD, and is intended for healthcare professionals only.
Host: Charles Flexner, MD
Daily oral therapy can have low adherence, which is why the field of long-acting formulations is rapidly advancing. Tune in to hear Dr. Charles Flexner discuss how long-acting regimens can address this problem of adherence and help patients living with HIV, tuberculosis, malaria, and other infectious diseases. Dr. Flexner is a Professor of Medicine of Pharmacology, Molecular Sciences, and International Health at Johns Hopkins University, and he also presented a session on this exact topic at the 2024 Conference on Retroviruses and Opportunistic Infections.
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Paul Feuerstadt MD, FACG, AGAF
C. difficile is a major problem in the United States. On top of that, patients who are diagnosed with this infection have the chance of getting caught in a vicious cycle of recurrence. So how can we provide our patients with the best care and work with them to give them the best treatment option? Learn more with Dr. Peter Buch as he takes a deep dive with Dr. Paul Feuerstadt, Assistant Clinical Professor of Medicine at Yale-New Haven Hospital.
Host: Jeffrey Kwong, DNP, MPH
Managing co-occurring conditions in patients with HIV can be challenging. But by taking certain steps—like updating management guidelines, screening for complications, and implementing prevention strategies—we can overcome those challenges and improve the way we care for HIV patients with co-occurring conditions. Here to discuss those strategies is Dr. Jeffrey Kwong, a Professor in the Division of Advanced Nursing Practice at Rutgers University School of Nursing. He also spoke about this exact topic at the 2023 Annual ANAC conference in his session, titled “Managing Co-Occurring Conditions: A Clinical Update.”
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: William R. Short, MD, MPH, AAHIVS
As of January 2023, the breastfeeding guidelines for HIV patients were updated, and they now recommend supporting the parent’s choice through shared decision-making. Joining Dr. Charles Turck to share what these new guidelines look like in practice and key counseling strategies for HIV patients is Dr. William Short. Dr. Short is an Associate Professor of Medicine and Infectious Disease at the University of Pennsylvania in Philadelphia, and he also spoke about this exact topic at the 2023 ANAC conference in his session, titled “New Recommendations for Infant Feeding for Persons with HIV in the United States.”
Host: Rachel Denyer, MD
About one in every three people living with HIV has a positive hepatitis B core antibody. But how frequently does hepatitis B reactivation occur after a patient with HIV switches to an antiretroviral regimen that has no hepatitis B activity? Find out with Dr. Rachel Denyer as she shares key data she presented at IDWeek 2023 in the session titled “Hepatitis B Reactivation in Persons with HIV with Positive Hepatitis B Core Antibody After Switching to Antiretroviral Therapy Without Hepatitis B Activity.”
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Stuart M. Levitz, MD
Treating fungal infections can be difficult due to the limited treatment options available, but could antifungal vaccines help change that? To catch us up on the progress being made in immunotherapeutic and vaccine strategies, Dr. Charles Turck speaks with Dr. Stuart Levitz about the “Antifungal Vaccines: Where Are We At?” session he presented at IDWeek 2023.
Host: Jeffrey Freiberg, MD, PhD
The field of infectious diseases is always evolving thanks to new research studies, data, and treatment options. To help us catch up on some of these essential updates, Dr. Jeffrey Freiberg is here to give us an overview of the “What's Hot in ID in Clinical Science” session he helped develop for IDWeek 2023.
Host: Jay Fishman, MD
With a global shortage of human organs, xenotransplantation offers a potential new way to save lives. But what are the immunologic barriers? Tune in as Dr. Jay Fishman, Director of Transplant Infectious Diseases and Compromised Host Program at Massachusetts General Hospital, recaps his session from the 2023 IDWeek.
Guest: Natalia Castillo Almeida, MD
感染流感会增加住院和罹患严重疾病的风险，尤其对高风险患者而言。幸运的是，接种流感疫苗可以帮助个人有效应对此类情况。在本节目中，内布拉斯加州大学医学院传染病系助理教授 Natalia Castillo Almeida 医生分享了关于住院率的关键数据和流感疫苗的接种建议。
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: John J. Russell, MD
Guest: Darvin Scott Smith, MD
Hospitals and health systems face several economic and logistical challenges due to low rates of flu vaccination. Fortunately, there are policies, programs, and initiatives that can be implemented in health system environments and at the community level to increase flu vaccination rates. Learn more with Drs. Darvin Scott Smith and John Russell. Dr. Smith is an Infectious Disease Consultant of Public Health Works, LLC in Northern California, and Dr. Russell is a family medicine physician at Jefferson Health System in Abington, Pennsylvania.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Keith C. Ferdinand, MD, FACC, FAHA, FASPC, FNLA
Vaccines are essential in reducing death and disability related to influenza, but unfortunately, not all patients have equal access to these life-saving resources. In fact, many barriers exist, like misinformation and lack of public awareness and education. That’s why Dr. Charles Turck speaks with Dr. Keith Ferdinand about ways we can break down barriers and improve vaccination rates among members of racial and ethnic minority communities.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Jill Foster, MD
The clinical and economic burden associated with the flu is particularly heavy for our youngest patients. Learn more about this burden and how influenza vaccines can help reduce it with Dr. Charles Turck and Dr. Jill Foster, Professor in the Department of Pediatrics and the Director of the Division of Pediatric Infectious Diseases at the University of Minnesota Medical School in Minneapolis.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Darvin Scott Smith, MD
There are several benefits associated with using real-world evidence to assess vaccine effectiveness, especially in the context of flu vaccines. Find out why and what the real-world evidence says about the effectiveness of flu vaccines with Dr. Charles Turck and Dr. Darvin Scott Smith. Dr. Smith is an infectious disease consultant of Public Health Works, LLC in Northern California.
Host: Joyce Riley
Guest: Lance Sloan, MD
Pneumococcal vaccination isn’t restricted to a specific season. Patients can get vaccinated with Prevnar 20 at any time. Clinicians can help their patients better understand the importance of pneumococcal vaccination. Join Joyce Riley as she gets expert insights from Dr. Lance Sloan, Endocrinologist, Nephrologist, and Metabolist in Lufkin, Texas.
Continuing medical education credits are not available for this program.
Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Guest: Steve Grinspoon, MD
The risk of cardiovascular disease is twice as great among patients living with HIV, and this could partly be due to traditional risk factors, along with nontraditional risk factors. Here to discuss the results from the REPRIEVE study with Dr. Mary Katherine Cheeley is Dr. Steve Grinspoon, Co-Principal Investigator and Professor of Medicine at Harvard Medical School in Boston.
Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Guest: Sarah Bauerle Bass, PhD, MPH, FSBM
Although the rate of new HIV diagnoses in the United States is steadily declining, people in prisons are still disproportionately living with the virus, which is why researchers at Temple University are now developing an app aimed at improving HIV prevention and substance use treatment access for incarcerated women in Philadelphia. To learn more about this research, Dr. Mary Katherine Cheeley is joined by Dr. Sarah Bauerle Bass, Associate Professor of Social and Behavioral Sciences and the Director of Risk Communication Laboratory at Temple University.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Kamel Khalili, PhD
Scientists at Temple University’s Lewis Katz School of Medicine have identified a novel gene-editing strategy aimed at eliminating HIV-1 infection with no adverse effects on cell mortality. Find out how this recent discovery could get us one step closer to a cure for HIV with Dr. Charles Turck and Dr. Kamel Khalili, the Laura H. Carnell Professor in the Department of Neuroscience and Chair of the Department of Microbiology, Immunology & Inflammation.
Host: Ryan Maves, MD
Guest: Kelly Pennington, MD
It’s estimated that respiratory syncytial virus (RSV) is responsible for up to 30 percent of viral respiratory infections in the stem cell transplant population. So how can we help RSV patients achieve their best outcomes? Learn more with Dr. Ryan Maves as he speaks with Dr. Kelly Pennington, Assistant Professor of Medicine at the Mayo Clinic in Rochester, Minnesota.
This program is produced in partnership with the American College of CHEST Physicians and is supported by an educational grant from GSK.
Host: Ryan Maves, MD
Guest: Megan Conroy, MD, MA(Ed)
Respiratory syncytial virus (RSV) is most commonly recognized for the significant disease it causes in infants and young children. However, over time its prevalence in adults has increased. Tune in to learn more with Dr. Ryan Maves as he speaks with Dr. Megan Conroy, Assistant Professor of Medicine at the Ohio State University in Columbus.
This program is produced in partnership with the American College of CHEST Physicians and is supported by an educational grant from GSK.
Host: Jerome Lisk, MD
Guest: Santosh Kumar, PhD
In an effort to examine the correlation between HIV-induced aging and Alzheimer’s disease in the United States population, a team of researchers at the University of Tennessee Health Science Center are working to develop a novel drug delivery system. To learn more, Dr. Jerome Lisk is joined by Dr. Santosh Kumar to discuss his current research and the effects it could have on future treatment approaches for HIV-induced aging and Alzheimer’s disease. Dr. Kumar is a Professor in the Department of Pharmaceutical Science at the University of Tennessee.
Host: Paul P. Doghramji, MD, FAAFP
Guest: Marci Drees, MD
How do the guidelines recommend keeping our patients safe during the flu season? Dr. Paul Doghramji takes a look at these recommendations—and how clinicians can counsel their patients on them—with Dr. Marci Drees, the Chief Infection Prevention Officer and Hospital Epidemiologist at ChristianaCare in Wilmington, Delaware.
Guest: Natalia Castillo Almeida, MD
Influenza can increase the risk of hospitalization and disease severity, specifically for high-risk patients. Fortunately, the influenza vaccine can help combat this. Join Dr. Natalia Castillo Almeida, an Assistant Professor in the Division of Infectious Diseases at the University of Nebraska School of Medicine, as she shares key data on hospitalization rates and recommendations for vaccination.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Avindra Nath, MD
Researchers from the National Institutes of Health (NIH) found that 100 percent of the participants in this study had fatigue and experienced cognitive difficulties. So what can we learn from this new research to help us diagnose and treat patients with disabling neurological symptoms after they had COVID-19? To discuss the findings, Dr. Charles Turck is joined by Dr. Avindra Nath, Clinical Director of the National Institute of Neurological Disorders and Stroke.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Paul Kwo, MD
Hepatitis B and C are both highly prevalent infections around the world. However, many individuals are not aware of their infection, which can lead to progressive liver damage and other health consequences. This is just one of the many unmet needs in the hepatitis care continuum, and joining Dr. Charles Turck to help uncover those unmet needs and discuss how the latest management strategies can help address them is Dr. Paul Kwo, Director of Hepatology at Stanford University.
Guest: Jason Goldman, MD
How are standard versus adjuvanted influenza vaccines made? Here to break down the manufacturing process for these types of influenza vaccines is primary care physician Dr. Jason Goldman.
Host: Marshall Miller
This episode of Rub Some Dirt in It is getting curiouser and curiouser. See if you can solve these two cases before host Marshall Miller reveals the rare and unexpected diagnoses.
Host: Paul P. Doghramji, MD, FAAFP
Guest: Jason Goldman, MD
Misconceptions continue to spread about the influenza vaccine during pregnancy. What are some ways we can address them? To answer this question, Dr. Paul Doghramji and Dr. Jason M. Goldman from the American College of Physicians explore the CDC’s recommendations and share strategies to challenge these assumptions.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Andrew Clark, MD
Emerging treatment options have helped patients with HIV live longer, but the aging population faces its own unique challenges. To explore how we can combat these challenges—including the ongoing stigma around HIV—Dr. Charles Turck is joined by Dr. Andrew Clark, who is the Global Medical Lead at ViiV Healthcare.
Host: Jennifer Caudle, DO
Guest: Christopher D. Altman, PharmD
Joining Dr. Jennifer Caudle to discuss how to talk to vaccine-hesitant patients about shingles vaccination and share insights is Dr. Christopher Altman, Director of Immunization and Clinical programs.
Sponsored by GSK
Host: Jennifer Caudle, DO
Guest: Christopher D. Altman, PharmD
Joining Dr. Jennifer Caudle to explore how we should approach vaccine hesitancy and address concerns about cost and time constraints for shingles vaccination is Dr. Christopher Altman, Director of Immunization and Clinical Programs.
Sponsored by GSK
Host: Jennifer Caudle, DO
Guest: Christopher D. Altman, PharmD
Counseling your patients about their risk of shingles—and encouraging them to get vaccinated—can help better protect them. But how do we do that? To answer this question, Dr. Christopher Altman discusses the risk of shingles with Dr. Jennifer Caudle.
Sponsored by GSK
Host: Jennifer Caudle, DO
Guest: Christopher D. Altman, PharmD
Shingles can impact many of our patients 50 years and older, which is why we need to talk to them about their risk. To take a look at counselling strategies, Dr. Jennifer Caudle is joined by Dr. Christopher Altman, Director of Immunization & Clinical Programs.
Sponsored by GSK
Host: Jennifer Caudle, DO
Guest: Christopher D. Altman, PharmD
How can we improve rates for shingles vaccination across all ethnicities? To find out how, Dr. Jennifer Caudle is joined by Dr. Christopher Altman to explore discrepancies in vaccination rates.
Sponsored by GSK
Host: Thomas F. Patterson, MD, FACP, FIDSA
Guest: George Thompson III, MD, FIDSA
The changing epidemiology of invasive fungal infections, ongoing antifungal resistance, drug-drug interactions, and few oral agents leave patients with limited viable treatment options. While the antifungal pipeline has been essentially dry for the past 2 decades, several antifungal drugs are now in late-stage clinical development and poised to address these unmet needs. But take heed: They will need to be treated as precious commodities lest they, too, become ineffective due to resistance.
Host: Peter G. Pappas, MD, FACP
Guest: Thomas F. Patterson, MD, FACP, FIDSA
Despite advances in diagnosis and treatment, as well as the dissemination of clinical practice guidelines, both the threat and burden of invasive fungal infections are increasing and underappreciated. Dr. Peter Pappas and Dr. Thomas Patterson, pioneers in this field, offer their perspectives on why this is the case and how a heightened awareness of invasive fungal infections is the key to improving your practice.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Paul Hunter, MD
It’s important to recognize that older adults are more susceptible to influenza infection—as well as increased severity of infection—than younger, healthier populations.1 Fortunately, there are vaccines available that can help prevent influenza in this aging population. But do the relative benefits and harms of higher-dose and adjuvanted vaccines, compared with one another and with other influenza vaccines, favor the use of any one or more of these vaccines over other age-appropriate options for people 65 and older?2 That's the exact question the CDC’s Advisory Committee on Immunization Practices (ACIP) sought to answer and what Dr. Charles Turck discusses with Dr. Paul Hunter, Associate Professor in the Department of Family Medicine and Community Health at the University of Wisconsin School of Medicine and Public Health.
References:
1. Centers for Disease Control and Prevention. Fly & People 65 Years and Older. Accessed August 16, 2022. https://www.cdc.gov/flu/highrisk/65over.htm.
2. National Center for Immunization & Respiratory Diseases. Advisory Committee on Influenza Practices. Influenza Vaccines for Older Adults: GRADE Summary. Accessed August 16, 2022.
USA-FLUD-22-0056 December 2022
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Natalia Castillo Almeida, MD
Patients in urban communities often face challenges when accessing influenza vaccines. But there are ways we can help address those geographic and socioeconomic barriers. Joining Dr. Charles Turck to share key strategies for improving influenza vaccination rates in urban communities is Dr. Natalia Castillo, Assistant Professor in the Division of Infectious Diseases at University of Nebraska Medical Center.
Host: Jennifer Caudle, DO
Guest: Jennifer Shu, MD, FAAP
Why is are we currently facing a tripledemic? Joining Dr. Jennifer Caudle to uncover what has led to this dramatic increase in COVID-19, RSV, and the flu—and share strategies to combat this tripledemic—is ReachMD Host Dr. Jennifer Shu, a pediatrician at Children’s Medical Group in Atlanta, Georgia.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Fatima, Adhi, MD
Guest: Mei Chang, PharmD
Collaborative care is fundamental for critically ill patients, especially when it comes to medication dosing. To explore key considerations on dosing and share insights from their presentations at IDWeek 2022, Dr. Charles Turck is joined by Dr. Adhi Fatima from the Baylor College of Medicine and Mei Chang from the Montefiore Medical Center at the Weiler Division Einstein Campus.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Jason Zucker, MD
The monkeypox outbreak has taken the nation by storm, leading to an increase in diagnostic and vaccination resources. But has this virus prepared us for future infectious disease outbreaks? Joining Dr. Charles Turck to share lessons we’ve learned from the monkeypox outbreak is Dr. Jason Zucker from the Columbia University Irving Medical Center.
Host: Charles P. Vega, MD
Guest: Paul G. Auwaerter, MD, MBA
Newer therapeutic options are now available to treat COVID-19. Don’t panic! Drs. Charles Vega and Paul Auwaerter are here to help you successfully integrate these therapeutics into your practice. Find out how to identify patients that are at risk for severe disease and select the appropriate treatment for the patient in front of you.
Host: Charles P. Vega, MD
Guest: David J. Cennimo, MD, FACP, FAAP, FIDSA
Clinicians treating patients in outpatient, urgent care, and emergent care settings who encounter patients with mild to moderate disease are tasked with providing optimal care to prevent disease progression. Drs. Charles Vega and David Cennimo take us through the spectrum of COVID-19 disease and identify available treatment options for your high-risk patients.
Host: Matt Birnholz, MD
Guest: David Canaday, MD
As we age, our immune system becomes weaker and is therefore unable to ward off infection as easily as in our younger years.1 This is particularly troublesome during flu season. In fact, the CDC’s Advisory Committee on Immunization Practices (ACIP) recently looked at flu vaccine data for adults aged 65 years and older, and they now recommend that this age group preferentially receive higher dose or adjuvanted vaccines over standard dose unadjuvanted vaccines when available.2 So what was the data that led to these updated recommendations? Joining Dr. Matt Birnholz to share those key findings and the role of adjuvanted vaccines like FLUAD® QUADRIVALENT (Influenza Vaccine, Adjuvanted) in preventing influenza in older adults is Dr. David Canaday, Professor in the Division of Infectious Diseases & HIV Medicine at Case Western Reserve University in Cleveland.
Avoid use in patients who have experienced any severe allergic reactions to any component of the vaccine. For more risk information please see below or consult the Full US Prescribing Information for FLUAD® QUADRIVALENT here.
References:
1. Gavazzi G, Krause KH. Ageing and infection. Lancet Infect Dis. 2002;2(11):659-666.
2. Centers for Disease Control and Prevention. Past seasons estimated influenza disease …
Host: Matt Birnholz, MD
Guest: David Canaday, MD
As we age, our immune system becomes weaker and is therefore unable to ward off infection as easily as in our younger years.1 This is particularly troublesome during flu season. In fact, the CDC’s Advisory Committee on Immunization Practices (ACIP) recently looked at flu vaccine data for adults aged 65 years and older, and they now recommend that this age group preferentially receive higher dose or adjuvanted vaccines over standard dose unadjuvanted vaccines when available.2 So what was the data that led to these updated recommendations? Joining Dr. Matt Birnholz to share those key findings and the role of adjuvanted vaccines like FLUAD® QUADRIVALENT (Influenza Vaccine, Adjuvanted) in preventing influenza in older adults is Dr. David Canaday, Professor in the Division of Infectious Diseases & HIV Medicine at Case Western Reserve University in Cleveland.
Avoid use in patients who have experienced any severe allergic reactions to any component of the vaccine. For more risk information please see below or consult the Full US Prescribing Information for FLUAD® QUADRIVALENT here.
References:
1. Gavazzi G, Krause KH. Ageing and infection. Lancet Infect Dis. 2002;2(11):659-666.
2. Centers for Disease Control and Prevention. Past seasons estimated influenza disease …
Guest: Francesca Taraballi, PhD
As mRNA therapeutics continue to evolve, what do we know about its potential in the treatment of infectious diseases? Dr. Francesca Taraballi from the Center for Musculoskeletal Regeneration at the Houston Methodist Hospital explores emerging mRNA therapeutics.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: William Schaffner, MD
Before recommending the new COVID-19 booster, what do we need to know about this vaccine, and which of our patients fit the criteria for it? To learn the latest on what experts have to say about the new COVID-19 booster, Dr. Charles Turck speaks with Dr. William Schaffner from the National Foundation for Infectious Diseases.
Host: Mario R. Nacinovich, Jr., MSc
Guest: Charles P. Gerba, MD
A recent case of polio emerging in New York City have clinicians questioning whether or not we need to be concerned about a spread. What do we need to know about this case—and our potential risk—of polio? Joining Mario Nacinovich to take a look at this case is microbiologist Dr. Charles Gerba, a Professor of Environmental Science at the University of Arizona.
Host: John J. Russell, MD
Guest: John P. Cooke, MD, PhD
mRNA was first discovered in the 1980s, and it wasn’t until recently that mRNA technology entered the spotlight. But how did we get to this point, and where do we go from here? Discover this and more with Dr. John Russell and Dr. John Cooke, Director of the Center for Cardiovascular Regeneration and Medical Director of the RNA Therapeutics Program in the Houston Methodist DeBakey Heart and Vascular Center.
Guest: John P. Cooke, MD, PhD
Message RNA (mRNA) is a copy of a gene within DNA. And based on how mRNA functions in the body, how can we leverage it to help protect us against infectious disease? Explore this and more with Dr. John P. Cooke, Director of the Center for Cardiovascular Regeneration and Medical Director of the RNA Therapeutics Program in the Houston Methodist DeBakey Heart and Vascular Center.
Host: Mario R. Nacinovich, Jr., MSc
Guest: Charles P. Gerba, MD
With rates of monkeypox continuing to rise, what do we need to know about this disease? And how easily can it spread from one person to another? Tune in to hear from renowned microbiologist, Dr. Charles Gerba, a Professor of Environmental Science at the University of Arizona as he explores these topics with Mario Nacinovich.
Host: Mario R. Nacinovich, Jr., MSc
Guest: Julia Bilinska, MD
Guest: Aatish Patel, MD
Monkeypox continues to spread around the globe, and its clinical manifestations can differ from what we’ve seen. What are the newest symptoms of this disease? Learn more about these manifestations from Drs. Aatish Patel and Julia Bilinska from Guy's and St. Thomas' NHS Foundation Trust in London as they talk about their research with Host, Mario Nacinovich.
Guest: Amy Mgonja, PharmD, BCGP, CPPS
Training pharmacists to administer vaccines can reduce barriers to immunizations and improve patient care. Here to discuss the ApHA Pharmacy-Based Immunization Delivery Program and the important role that pharmacists play in educating and vaccinating patients is Dr. Amy Mgonja, clinical consultant pharmacist at Dawa Rx Consulting.
Host: Jennifer Caudle, DO
Guest: Roni Devlin, MD
As rates of burnout continue to rise in the healthcare community, how can help our female physicians combat it? Dr. Jennifer Caudle joins Infectious Disease Specialist, Dr. Roni Devlin, to discuss how we can prevent burnout for female physicians.
Host: Jennifer Caudle, DO
Guest: Wendy Wright, DNP, FNP-BC, ANP-BC, FAANP, FAAN, FNAP
Guest: Gary Marshall, MD
It's well understood that annual vaccination is the best way to help reduce the high burden associated with influenza. And while most influenza vaccines available in the United States are produced in eggs, this presents some inherent challenges, which can lead to reduced vaccine effectiveness. Fortunately, alternative production processes can help us overcome those challenges, and to learn more, Dr. Jennifer Caudle speaks with Dr. Wendy Wright and Dr. Gary Marshall.
USA-CRP-22-0018 May 2022
Host: John J. Russell, MD
Guest: Randy Young, MD
As Monkeypox continues to spread across non-endemic countries more and more, how can we detect it in our patients? And what’s being done to stop the spread? Guest and fellow ReachMD Host Dr. Randy Young, a Pulmonary Disease and Critical Care Medicine physician, joins Dr. John Russell to discuss what physicians should be looking out for, and how this virus has impacted public health.
Host: Michael Greenberg, MD
Guest: Esther Freeman, MD, PhD
Guest: Steven Chen, MD, MPH, MHPEd
With the recent rise of monkeypox cases around the world, dermatologists will be some of the first to evaluate and diagnose patients with the disease. So to help those on the frontlines, Dr. Esther Freeman, Director of Global Health Dermatology at Massachusetts General Hospital and Dr. Steven Chen, Assistant Professor of Dermatology at Harvard Medical School, share what dermatologists need to know about monkeypox.
Host: Peter Buch, MD, FACG, AGAF, FACP
The COVID-19 pandemic has entirely transformed the educational community, especially for medical students. To find out more about this impact, Dr. Peter Buch is joined by two fourth-year medical school students, Miss Sheila Eghbali and Mr. Kyle Glose, to discuss their experiences.
Host: John J. Russell, MD
Guest: Amesh Adalja, MD
Monkeypox is not something we’re used to seeing in non-endemic countries like North America and Europe. Yet its spreading has some experts scratching their heads. Dr. Amesh Adalja, a Senior Scholar at the Johns Hopkins Center for Health Security at the Bloomberg School of Public Health, shares with Dr. John Russell what clinicians need to know about monkeypox amid the global outbreak in non-endemic countries.
Host: Charles Turck, PharmD, BCPS, BCCCP
Over the course of the COVID-19 pandemic, the healthcare field has been hit hard—facing employment challenges, increased burnouts, and more. Yet salaries have been slow to rise, and conditions haven't improved. Dr. Thuy Nguyen from the University of Michigan School of Public Health joins Dr. Charles Turck to share how employment in the healthcare field has changed over the course of the COVID-19 pandemic.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Trevor Cabrera, MD
What’s it like becoming a locum tenens physician right out of residency? Dr. Charles Turck joins Dr. Trevor Cabrera, a Board-Certified pediatrician who trained in Houston, Texas, to share his firsthand experience and offer advice for residents.
Host: Paul P. Doghramji, MD, FAAFP
Guest: Samantha Conroy, MD
Locum tenens can improve quality of care around the globe—especially in remote and underserved communities. To share how, Dr. Paul Doghramji joins Dr. Samantha Conroy, a family practice obstetrician to share her experiences working as a locum tenens obstetrician in underserved communities.
Host: Jennifer Caudle, DO
Guest: Maurice G. Sholas, MD, PhD
After years of serving the New Orleans community, one physician decided to pursue locum tenens work. Dr. Jennifer Caudle joins Dr. Maurice Sholas, a pediatric physical rehabilitation physician, to share his experiences with locum tenens and in New Orleans.
Host: Richard Elion, MD
Sexual histories are a vital part of ensuring a patient’s well-being. Nonetheless, many providers are uncomfortable taking a sexual history for an individual who may be at increased risk for acquiring HIV. The ability to offer a preventative medication for HIV acquisition is a cornerstone for informed consent for sexual health. Join Dr. Richard Elion as he takes us through a patient-clinician dialogue demonstrating how to take a sexual history that is complete, respectful, and nonjudgmental.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Heather Moday, MD
When we say the words behavior, diet, habits, and environment, chances are you don't think of the body's immune system. But based on recent research, all of those factors play a role in influencing immune function. So how can we keep them in mind and boost our immunity in the face of prevalent diseases, including COVID-19? Find out with Dr. Charles Turck as he speaks with Dr. Heather Moday, author of The Immunotype Breakthrough: Your Personalized Plan to Balance Your Immune System, Optimize Health, and Build Lifelong Resilience.
Host: David A. Wohl, MD
Guest: Lisa Hightow-Weidman, MD, MPH
The CDC’s 2021 update to their PrEP guidelines recommend that PrEP should be offered to all individuals who want or need it. Although PrEP is both safe and extremely effective, persistence to PrEP in the long-term is low, at about 40% at 2 years. Join Drs. Wohl and Hightow-Weidman as they discuss the challenges associated with increasing PrEP uptake and how the emergence of a long-acting injectable PrEP formulation could result in improved long-term persistence.
Host: Neilanjan Nandi, MD
Guest: Jean-Frederic Colombel, MD
There are over a half dozen newer and emerging classes of agents for ulcerative colitis. This abundance is great news for our patients, but it also increases the complexity of treatment. Listen in as Dr. Neil Nandi and Dr. Jean-Frederic Colombel explore the roles that these agents will play in the evolving treatment landscape.
Since the completion of this activity, results from the ELEVATE UC 52 study, a yearlong phase 3 trial of etrasimod in moderate to severe ulcerative colitis, were announced. Etrasimod is an investigational, oral, once-a-day, selective sphingosine 1-phosphate (S1P) receptor modulator that showed positive 12- and 52-week results compared to placebo. Patients achieved statistically significant improvements in the co-primary endpoint of clinical remission at weeks 12 and 52 when compared to placebo. Statistically significant improvements were also attained in all key secondary endpoints at both 12 and 52 weeks. We will provide more data as the full results are published and presented in the future.
Host: Neilanjan Nandi, MD
Guest: David T. Rubin, MD
The proliferation of new classes of therapies for ulcerative colitis is affecting how we decide which treatments are most appropriate for our patients who are first- or second-line non-responders. This creates not only new challenges, but also new opportunities for all community gastroenterologists. Dr. Neil Nandi and Dr. David Rubin walk us through a case to highlight some of these challenges.
Since the completion of this activity, results from the ELEVATE UC 52 study, a yearlong phase 3 trial of etrasimod in moderate to severe ulcerative colitis, were announced. Etrasimod is an investigational, oral, once-a-day, selective sphingosine 1-phosphate (S1P) receptor modulator that showed positive 12- and 52-week results compared to placebo. Patients achieved statistically significant improvements in the co-primary endpoint of clinical remission at weeks 12 and 52 when compared to placebo. Statistically significant improvements were also attained in all key secondary endpoints at both 12 and 52 weeks. We will provide more data as the full results are published and presented in the future.
Host: Rachel Caskey, MD, MAPP
Guest: Gwendolyn Ramirez
Vaccine hesitancy is a very challenging, and often tiring topic, for clinicians to address. Join Dr. Rachel Caskey in an engaging clinician-patient dialogue as she uses a dynamic and presumptive approach to overcome common vaccination challenges. What communication pearl will you use with your patients?
Host: John J. Russell, MD
Guest: Drew Weissman, MD, PhD
Guest: Katalin Karikó, PhD
As mRNA technology continues to emerge and evolve, Penn Researchers Dr. Drew Weissman and Dr. Katalin Karikó join Dr. John Russell to take a deep dive into the future of mRNA technology.
Guest: Pranay Sinha, MD
Where are we on the path to eliminating tuberculosis? To understand this, Dr. Pranay Sinha, a postdoctoral researcher at Boston Medical Center, discusses what we need to know and shares what’s on the horizon for TB elimination.
Host: Hector O. Chapa, MD, FACOG
Guest: Dani Dumitriu, MD, PhD
The COVID-19 pandemic has taken a toll on all patients, especially pregnant women. Here to walk us through her research on the pandemic's impact on the psychosocial health of mothers and the neurodevelopment of their fetuses is Dr. Dani Dumitriu, a pediatrician, neuroscientist, and pediatric environmental health scientist at Columbia University in New York.
Host: Carol Wysham, MD
Guest: Deepak Vashishth, PhD
Guest: Bowen Wang
Can we predict when a patient with COVID-19 requires hospitalization? To answer this question, Dr. Carol Wysham is joined by Dr. Deepak Vashishth and Mr. Bowen Wang from the Rensselaer Polytechnic Institute to share data from their study on the impact of glycemic levels and common medications on COVID-19 severity in patients with type 2 diabetes.
Host: John J. Russell, MD
Guest: Benjamin Abramoff, MD, MS
Once a patient is discharged from the hospital after battling COVID-19, the war they face with this disease may not be over. In fact, many patients continue to experience long-term effects, which is why some institutions have formed clinics that are solely dedicated to caring for these patients. To learn more about how one such clinic is helping patients manage these devastating effects, Dr. John Russell speaks to physiatrist Dr. Benjamin Abramoff from the Post-COVID Assessment and Recovery Clinic at Penn Medicine in Philadelphia.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: William Schaffner, MD
From widespread variants to the threat of a twindemic -- what has the COVID-19 pandemic taught us? And can we learn to coexist with this virus? Dr. Charles Turck is joined by Dr. William Schaffner from the National Foundation for Infectious Diseases to discuss what's on the horizon for the pandemic.
Host: Hector O. Chapa, MD, FACOG
Guest: Linda Bradley, MD
While many people across the country have access to COVID-19 vaccines, there are certain communities where access is not as easy. So what can we do to address the vaccination gaps and barriers to care during the COVID-19 pandemic and beyond? Find out with Dr. Hector Chapa as he speaks with Dr. Linda Bradley from Case Western Reserve University, who shares a brief history of the presence of social determinants of health and racial disparities across our nation and how they impact our current vaccination efforts.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Chris Beyrer, MD, MPH
Amid the ongoing COVID-19 pandemic, countries in Sub-Saharan Africa are also facing high rates of HIV and AIDS prevalence. But after the success of the mRNA COVID-19 vaccines, could an mRNA vaccine for HIV/AIDS be on the horizon? Here to explore emerging research and the potential role that mRNA technology might have in battling this global epidemic is Dr. Chris Beyrer, a Professor of Epidemiology at the Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland.
Guest: Jeniffer Hernandez, PhD
Over 1.5 million viruses could potentially cause a future pandemic. Could antibodies be the key to neutralizing those viruses? Here to share how future vaccination efforts might incorporate neutralizing antibodies and her research on preventing future pandemics is Dr. Jeniffer Hernandez, Associate Professor of Biopharmaceutical Sciences at the Keck Graduate Institute.
Host: John J. Russell, MD
Guest: Jessica Malaty Rivera, MS
Social media and the ability to quickly spread information across the internet has allowed misinformation surrounding COVID-19 vaccines and the disease itself to spread like wildfire. But the good news is that when armed with effective counseling strategies and data from initiatives like the COVID-19 Tracking Project, we as clinicians can help stop the spread of harmful conspiracies and myths. Joining Dr. John Russell to talk about those essential strategies and the COVID-19 Tracking Project is infectious disease epidemiologist Ms. Jessica Rivera.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Jeffrey D. Cirillo, PhD
How prevalent is tuberculosis in long-term care facilities? To better understand this, Dr. Charles Turck meets with Dr. Jeffrey Cirillo to examine screening and testing strategies to better monitor TB risk, specifically for high-risk patient populations.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Laila Woc-Colburn, MD, DTM&H, FACP, FIDSA
What are some ways we can better care for our patients prior to starting biologic therapy? Dr. Charles Turck joins Dr. Laila Woc-Colburn from the Emory University School of Medicine to discuss ways to improve safety for patients with tuberculosis.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Sandy Marks
Guest: Kim Horvath, JD
Guest: Kyle Thomson, JD
With telehealth services expanding during the COVID-19 pandemic, has our access to them changed? To better understand this, Dr. Charles Turck meets with Sandy Marks, Kim Horvath, and Kyle Thomson from the AMA to explore what’s been done to provide Medicare coverage during a public health emergency and what’s on the horizon for telehealth access.
Host: Mimi Secor, DNP, FNP-BC, FAANP
Guest: Maria Trent, MD, MPH, FAAP, FSAHM
Dr. Mimi Secor is joined by Dr. Maria Trent to discuss mycoplasma genitalium (MGen), how we can better understand this infection and help reduce our patients' risk of it.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Emily Carroll, JD, MSW
The No Surprises Act aims to protect consumers from surprise medical bills. But how exactly does it go about doing that, and what’s the current status of its implementation? Joining Dr. Charles Turck to share progress and challenges associated with the No Surprises Act is Ms. Emily Carroll, a senior legislative attorney for the American Medical Association's Advocacy Resource Center.
Host: Jennifer Caudle, DO
Guest: Sarah Ali, MD
From working in a big city to taking on an assignment in a small mountain village, Dr. Sarah Ali from the Ventura County Medical Center joins Dr. Jennifer Caudle to talk about her adventures abroad with locum tenens and share key lessons she learned along the way.
Host: Jerome Lisk, MD
Guest: Tissa Wijeratne MD PhD FRACP FRCP FAAN
Since the onset of the COVID-19 pandemic, researchers and clinicians alike have strived to address the mysteries surrounding the virus, including its long-term side effects on patients. So what we do need to know about the emerging syndrome pointing to COVID-19’s neurological and cognitive impacts? To find out, Dr. Jerome Lisk is joined by Dr. Tissa Wijeratne, the Director of the Department of Neurology and Stroke Services at the University of Melbourne, to talk about post-COVID-19 neurological syndrome.
Guest: Maureen Brogan, MD
The COVID-19 pandemic has impacted care across all specialties, and the 2021 American Society of Nephrology (ASN) Annual Meeting offered a platform for nephrologists to share their experiences. Tune in to hear how Dr. Maureen Brogan adapted her practice to overcome supply and staffing shortages.
Host: Jennifer Caudle, DO
Guest: Erik Munson, Ph.D
Mycoplasma genitalium (M. gen) is an STI that shares similar health consequences to chlamydia and gonorrhea. Further complicating this health threat is the fact that there’s been little guidance on how to manage this new pathogen until recently when the 2021 STI Treatment Guidelines were released. Joining Dr. Jennifer Caudle to talk about M. gen and why the guidelines recommend the use of nucleic acid amplification tests for the diagnosis of this pathogen is Dr. Erik Munson, an Assistant Professor of Clinical Laboratory Science at Marquette University.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Onyema Ogbuagu MBBCh, FACP, FIDSA
With so many questions and confusion points surrounding booster shots, what do we need to know? Dr. Charles Turck is joined by Dr. Onyema Ogbuagu, Associate Professor in the section of Infectious Diseases at Yale University School of Medicine, to answer common questions regarding the COVID-19 vaccine booster shots.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Mark Blatter, MD
Despite their crucial role in preventing seasonal influenza, traditional influenza vaccines may not be providing as much protection as we thought, leading researchers to take a look at different methods of vaccine production, specifically cell-based flu vaccine production. Here with Dr. Charles Turck to discuss influenza prevention and the latest evidence supporting a cell-based vaccine option is Dr. Mark Blatter.
USA-QIVc-21-0146 November 2021
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Animesh Ray, PhD
Getting ahead of the next pandemic may be possible thanks to deep machine learning’s ability to predict the structure of antibodies. And while that may sound like science fiction, this technology is currently being studied, which is why Dr. Animesh Ray from the Keck Graduate Institute joins Dr. Charles Turck to provide insight on where the research currently lies and what we have to look forward to.
Host: Mimi Secor, DNP, FNP-BC, FAANP
Guest: Maria Trent, MD, MPH, FAAP, FSAHM
Dr. Mimi Secor is joined by Dr. Maria Trent, Chief of the Division of Adolescent and Young Adult Medicine at Johns Hopkins School of Medicine, to discuss diagnosing and treating antibiotic resistant MGen.
Guest: Randy Cron, MD, PhD
Dr. Randy Cron, Professor of Pediatrics and Medicine at the University of Alabama at Birmingham and the Director of the Division of Pediatric Rheumatology at Children’s of Alabama, shares highlights from his session on “Rheumatology Complications of Emerging Viral Infections and SARS-CoV-2” from the 2021 American College of Rheumatology Convergence.
Host: Jinoos Yazdany, MD, MPH
Which of our patients with rheumatic diseases are at higher risk for severe outcomes from COVID-19? That’s the exact question Dr. Jinoos Yazdany, Chief of the Division of Rheumatology at Zuckerberg San Francisco General Hospital, addresses in her presentation at the 2021 American College of Rheumatology (ACR) Convergence.
Guest: Muthiah Vaduganathan, MD, MPH
What do we currently know about the cardiac consequences of the COVID-19 vaccines? Dr. Muthiah Vaduganathan, cardiologist and investigator at Brigham Women's Hospital at Harvard Medical School, addresses the cardiac concerns surrounding the vaccines and how we can talk to patients about them.
Host: Paul P. Doghramji, MD, FAAFP
Guest: Mojgan Saber, MD
Can Locum Tenens be an option for healthcare professionals just completing their residency? Dr. Paul Doghramji is joined by Dr. Mojgan Saber to share her own experience as well as tips and tricks for residents looking at Locum Tenens right after residency.
Host: Mario R. Nacinovich, Jr., MSc
Guest: Randy Young, MD
Amid the surge of the Delta variant, critical care physician Dr. Randy Young is traveling to ICUs across the country to help treat patients. Tune in to hear Dr. Young share how this surge is impacting both patients infected with the variant and the healthcare professionals caring for them.
Host: Ricardo Franco, MD
Guest: David L. Wyles, MD
The COVID-19 pandemic has taken a disproportional toll on already vulnerable persons, yet substance use, psychosocial comorbidities, and preexisting disparities in access to care may translate to an even greater adverse impact among persons with chronic HCV. This educational activity offers up-to-date information on the impact of COVID-19 on the normal and HCV-infected liver, practical strategies for optimizing telehealth-delivered HCV care, and other recommendations for engaging vulnerable populations in HCV care during times of reduced service capacity.
Host: Paul Nyirjesy, MD
The global burden of acute vulvovaginal candidiasis (VVC) and the substantial morbidity and poor quality of life associated with recurrent disease (RVVC) requires improved solutions and quality of care for affected women. Join Dr. Paul Nyirjesy as he dissects the barriers to managing VVC and RVVC in your clinical practice and provides both diagnostic and therapeutic guidance inclusive of newly emerging and novel agents. These agents have unique qualities that may well represent a significant step forward in how you manage this challenging infection.
Host: Jennifer Shu, MD, FAAP
Tune in to hear pediatrician Dr. Jennifer Shu share what we currently know about the risks and impacts of the Delta variant on our youngest patients and perhaps even more importantly, how we can help keep them safe.
Published September 23, 2021
Host: Jennifer Shu, MD, FAAP
School’s back in session, and that means it’s time we take a look at how we can help keep children safe and healthy both inside and outside the classroom with pediatrician Dr. Jennifer Shu.
Published September 21, 2021
Host: Ricardo Franco, MD
Guest: Charles P. Vega, MD
Armed with Centers for Disease Control and Prevention (CDC) guidelines for HCV universal screening and risk-based testing — and an understanding of the simplicity of prescribing and managing direct-acting antiviral (DAA) therapies — primary care providers (PCPs) will be well equipped to step up and provide comprehensive HCV care and cure. This educational activity offers practical tips and tactics to prepare PCPs for their central role in eliminating HCV.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Pradipta Ghosh, MD
Artificial intelligence (AI) is rapidly changing how we practice medicine in a variety of ways, especially in the midst of the COVID-19 pandemic. In fact, a recently developed AI model can help us predict the disease course of patients infected with COVID-19, and here to share how that model was developed based on pandemics of the past and how it can be used in the current—and even future—pandemics is Dr. Pradipta Ghosh, Professor of Cellular and Molecular Medicine at UC San Diego.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Alberto Augsten, PharmD
During the COVID-19 pandemic, many patients turned to alcohol as a way to cope with this sudden and unprecedented global health crisis, and the rates of alcohol dependency are only continuing to rise according to recent studies. That’s why Dr. Charles Turck speaks with board-certified clinical toxicologist Dr. Alberto Augsten to help us better understand the challenges in screening patients for alcohol dependency amid the COVID-19 pandemic and how we can overcome those barriers to get our patients the best—and necessary—treatment.
Published August 20, 2021
Host: Cassandra B. Donnelly, DO
Guest: Charles P. Vega, MD
Post-exposure influenza prophylaxis should be a top-of-mind discussion with patients receiving an influenza diagnosis. Unfortunately, it remains an underused means to reduce secondary infections in at-risk households. Join Drs. Cassandra Donnelly and Charles Vega as they examine an extended patient case and offer practical strategies to overcome common clinical barriers surrounding post-exposure influenza prophylaxis, including how to match the right patient with the right antiviral treatment.
Guest: Susan Butler-Wu, PhD, D(ABMM), SM(ASCP)
Dr. Susan Butler-Wu, Associate Professor of Clinical Pathology and Director of Medical Microbiology at LAC+USC Medical Center, investigates the differences—and highlights the benefits—of PCR versus antigen testing for COVID-19.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Gail Saltz, MD
The quarantine blues may have come to an end, but as the country continues to reopen, a whole new set of mental health challenges are just beginning. So how can we help our patients who found comfort in social distancing and mask-wearing mandates navigate this change and return to public places? To find out, Dr. Charles Turck speaks with psychiatrist Dr. Gail Saltz, who discusses the lasting effects of the quarantine blues, how we can help patients who are suffering from anxiety, and more.
Host: Cassandra B. Donnelly, DO
Guest: Charles P. Vega, MD
Antiviral agents are underutilized against influenza in clinical practice, a failure that places many patients, especially those with comorbidities, at high risk for influenza-associated complications. Join Drs. Cassandra Donnelly and Charles Vega as they explore management strategies for patients with symptomatic influenza, compare and contrast clinical applications for the available antiviral agents, and reflect upon the increasing use of these agents as post-exposure influenza prophylaxis.
Guest: Jeffrey R. Starke, MD
Host: Paul P. Doghramji, MD, FAAFP
Dr. Paul Doghramji joins Dr. Jeffrey Starke, an Infection Control Officer at Texas Children’s Hospital and a Professor of Pediatric Infectious Disease Medicine at Baylor College of Medicine, to discuss the impact that the COVID-19 pandemic has had on testing for tuberculosis.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Paul Nyirjesy, MD
Guest: Christina Muzny, MD
Diagnosing vaginal infections early and accurately is key, but are current testing methods for vaginal infections facilitating early diagnosis? Joining Dr. Charles Turck to help answer this question are Drs. Christina Muzny and Paul Nirjesky, who share their multidisciplinary viewpoints on vaginal infections and diagnostic practices in women’s health.
Host: Andrew Wilner, MD, FACP, FAAN
Guest: William W. Li, MD
As the number of new COVID-19 infections continues to decrease and the United States begins to open back up, it’s important to note that there are patients who have survived COVID-19 but are still suffering. The newly coined term “COVID long-haulers” refers to those patients who continue to have symptoms even after the acute infection is resolved. Joining Dr. Andrew Wilner to share what we know so far about COVID long-haulers and how we can help them is vascular biologist Dr. William Li.
Host: John J. Russell, MD
Guest: Paul Farmer, MD, PhD
Dr. John Russell meets with Dr. Paul Farmer, the Chair of Global Health at Harvard Medical School and co-founder of Partners in Health, to review past pandemics and outbreaks while discussing things we can do as a community to lower the risk of these events.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Chris H. Cooper
Can new mask technology made with innovative materials better protect us from the coronavirus? Dr. Charles Turck speaks with Chris Cooper, Chief Science Officer and CEO of Airlock389, on improving mask technology after the supply shortage of masks during COVID-19.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Ana C Zamora Martinez, MD
The COVID-19 pandemic led many clinicians to make life-altering decisions. Dr. Ana Zamora, a pulmonary disease and critical care specialist, discusses her work with Locum Tenens and why she decided it was time for a change.
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Asher A. Kornbluth, MD
Since the onset of the COVID-19 pandemic, many questions have arisen regarding the care of our patients with IBD. Are they at increased risk of COVID-19? How should we treat a patient with IBD who has active COVID-19? Should they get vaccinated, and if so, when? These are all questions Dr. Peter Buch addresses with Dr. Asher Kornbluth, Clinical Professor of Medicine and Gastroenterology at Mount Sinai School of Medicine in New York, to help us optimize our approach to care amid the COVID-19 pandemic.
Host: Paul Doghramji, MD
Guest: Nadine Nakazawa, RN, BS
How does the patient-centric experience model for vascular access care differ from what we're used to doing, and what does it actually look like in practice? Joining Dr. Paul Doghramji to share what we need to know about the development and goals of patient-centered vascular access care is Ms. Nadine Nakazawa, a vascular access nurse specialist at Stanford Health Care.
Guest: Carlos del Rio, MD
Guest: Angela Rasmussen, PhD
With cases of COVID-19 surpassing 51 million worldwide, the rush to develop a vaccine capable of slowing the pandemic and lessening the morbidity and mortality of SARS-CoV-2 is underway. Several COVID-19 vaccines are now being studied in phase 3 trials, and clinicians would benefit from a review of these ongoing efforts, particularly the status of vaccines close to approval. This podcast will provide clinicians a review of up-to-date safety and efficacy information on vaccine candidates in late-stage development, and steps to prioritize patients who would benefit most from vaccination once available.
Guest: James Lewis II, PharmD, FIDSA
Guest: George Thompson III, MD, FIDSA
Have you ever wondered what went wrong in the management of invasive fungal infections? Through a storytelling approach Dr. James Lewis & Dr. George Thompson discuss a clinical story and identify where medical misses may have occurred. Supportive evidence will be provided on how care should have been provided and strategies for clinicians to apply in their practice.
Host: Jennifer Shu, MD, FAAP
Guest: Ramiz Kseri, MD
What are some factors leading to disparities in care for our LGBTQ patients, and how do we keep them safe amid the pandemic? Dr. Jennifer Shu is joined by Dr. Ramiz Kseri, an Internist and Pediatrician and an Assistant Professor of Clinical Sciences at Florida State University College of Medicine, to discuss how the LGBTQ community is affected by COVID-19 and other health risks.
Host: Mindie H. Nguyen, MD, MAS, AGAF, FAASLD
Guest: Joseph Lim, MD
Guest: Danny Chu, MD
Guest: Jian Q. Zhang, DNP, MS, FNP-BC, NEA-BC, FAAN
Experts in chronic hepatitis B within Asian communities discuss prevention, screening and management options to reduce the number of new cases and the risk of progression to cirrhosis, hepatic failure, and hepatocellular carcinoma. Experts also will consider the integration of Western and Eastern Medicine approaches to treatment and how cultural perceptions and community stigmatization of persons of Asian descent with chronic HBV infection can create barriers to diagnosis and care.
Host: Neilanjan Nandi, MD
Guest: Freddy Caldera, DO
Many IBD patients have received their COVID-19 vaccine, but many others still have reservations due to the abundance of myths and misconceptions surrounding the COVID-19 vaccines. That’s why Dr. Neil Nandi welcomes Dr. Freddy Caldera to discuss these common fears and challenges as well as some of the very best answers to address the concerns of our immunosuppressed IBD patients.
Host: Neilanjan Nandi, MD
Guest: David T. Rubin, MD
With more data emerging on COVID-19 vaccines every day, what do our patients with inflammatory bowel disease need to know about the vaccine currently available? Dr. Neil Nandi will be discussing these updates and how we can keep our patients safe with Dr. David Rubin, Professor of Medicine at the University of Chicago Pritzker School of Medicine.
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Colin T. Swales, MD
How can we help the two to four million Americans who are living with hepatitis C? Joining Dr. Peter Buch to answer this question and share treatment strategies for various case scenarios is hepatologist Dr. Colin Swales, Assistant Medical Director of Transplant Services at Harvard Hospital.
Host: Jennifer Caudle, DO
Guest: Kelly Cawcutt, MD
How has the COVID-19 pandemic changed vascular access paradigms in the intensive care unit? Joining Dr. Jennifer Caudle to share her story and lessons learned from the pandemic is Dr. Kelly Cawcutt, an Assistant Professor in the Department of Internal Medicine and the Associate Medical Director of Infection Control and Epidemiology at the University of Nebraska Medical Center.
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Andres Nieto, MD
The COVID-19 pandemic has demonstrated the effectiveness of telemedicine, but will this approach still be utilized after the pandemic ends? Dr. Peter Buch is joined by Dr. Andres Nieto, Assistant Professor at Frank H. Netter MD School of Medicine, to discuss the role of telemedicine and its future
Host: Jennifer Caudle, DO
Guest: Archana Chatterjee, MD, PhD
Since adults 65 years and older bear the greatest burden of severe disease from influenza, it’s critically important to ask ourselves the following question: what can we do to better prevent seasonal influenza infections in older adults? Here to answer that and other practical questions is Dr. Archana Chatterjee, MD, PhD, Dean of the Chicago Medical School and Vice President for Medical Affairs at Rosalind Franklin University in Chicago, IL.
USA-CRP-21-0004 January 2021
Host: Edward J. Mayeaux, Jr., MD, DABFP, FAAFP
Guest: Paul P. Doghramji, MD, FAAFP
Adherence to CDC vaccination recommendations is a public health issue and a topic of great concern for clinicians. According to the World Health Organization, vaccines ultimately reduce the burden of infectious disease and have the potential to save 2 to 3 million lives a year worldwide independent of their impact on morbidity. Join us as Drs. E.J. Mayeaux and Paul Doghramji discuss the challenges we’re all facing to overcome vaccine hesitancy and improve vaccine uptake, especially during the COVID-19 pandemic.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Ping Zhang, PhD, FAMIA
The pandemic continues to wreak havoc across the world, but a new deep learning computer model may have discovered ten potential treatment options to combat COVID-19. Dr. Charles Turck sits down with Dr. Ping Zhang, who leads the Artificial Intelligence in Medicine Lab and a faculty member at the Translational Data Analytics Institute at The Ohio State University, to discuss his team's findings.
Published March 29, 2021
Host: Andrew Wilner, MD, FACP, FAAN
Guest: Jennifer A. Frontera, MD
Although the impact of COVID-19 can be long-lasting, many have had similar effects, even if they aren’t diagnosed with the disease. Dr. Jennifer Frontera, a neurocritical care specialist and professor of neurology at the NYU Grossman School of Medicine, shares some insight on the neurological symptoms that patients with COVID-19 are facing.
Host: Paul Doghramji, MD
Guest: Sarojini Qasba, MD
With the World Health Organization’s goal to eliminate tuberculosis by 2030 quickly approaching, what can we be doing now to help us meet that goal? Joining Dr. Paul Doghramji to discuss three key factors and how the COVID-19 pandemic has impacted this global goal is Dr. Sonia Qasba, an infectious disease specialist at the Suburban Hospital in Bethesda, Maryland.
Host: Jennifer Caudle, DO
Guest: John J. Russell, MD
As clinicians on the frontlines of the COVID-19 pandemic, we’re among the first to hear about our patients’ fears of the vaccines’ validity and safety. So how can we help address their concerns? ReachMD hosts Dr. Jennifer Caudle and Dr. John Russell sit down together to talk about how we can counsel patients who may be hesitant to receive the COVID-19 vaccine.
Published March 16, 2021
Host: Andrew Wilner, MD, FACP, FAAN
Guest: Ken Tyler, MD
Further complicating the COVID-19 pandemic is the emergence of viral variants. Dr. Ken Tyler from the University of Colorado School of Medicine shares with us what we know so far about the COVID-19 variants that are quickly spreading around the world.
Host: Carol Wysham, MD
Guest: Alexis McKee, MD
Patient care has evolved amid the COVID-19 pandemic, causing unexpected challenges in managing diseases such as diabetes. Dr. Carol Wysham joins Dr. Alexis McKee, a practicing endocrinologist and an assistant professor of medicine at Washington School of Medicine in St. Louis, Missouri, to discuss how patients have been overcoming challenges in managing diabetes during the pandemic.
Host: Matt Birnholz, MD
In honor of our “Heroes in Healthcare” initiative, Dr. Matt Birnholz recounts some of the many healthcare professionals nominated by their peers who’ve bravely helped their patients combat the COVID-19 pandemic.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Frank Scott
Dr. Charles Turck is joined by Dr. Frank Scott from the University of Colorado School of Medicine to share some highlights from his session, “Challenges and New Approaches to Managing IBD in the COVID-19 Era,” at Crohn’s & Colitis Congress 2021.
Host: Matthew J. Sorrentino, MD, FACC, FASH
Guest: Suneet Mittal, MD FACC FHRS
The development of cardiac devices enhanced by wireless remote monitoring has changed the way cardiologists care for their patients. With that in mind, Dr. Matthew Sorrentino discusses remote monitoring in cardiology with Dr. Suneet Mittal, medical director of the Snyder Center for Comprehensive Atrial Fibrillation at the Valley Hospital in Ridgewood, New Jersey.
Host: De De Gardner, DrPH, RRT, RRT-NPS, FAARC, FCCP
Guest: Stephanie Briney, DO
Despite widespread availability, only half of Americans received the flu shot last year. With that in mind, Dr. De De Gardner is joined by Dr. Stephanie Briney, Assistant Professor in Family, Community, and Preventive Medicine at the University of Arizona College of Medicine, Phoenix to discuss why Americans avoid getting the flu shot and how she approaches this in her practice.
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Myron Brand, MD
While many know that COVID-19 can affect the respiratory system, but how can this disease also influence the gastrointestinal tract? Tune in to hear Dr. Peter Buch discuss with Dr. Myron Brand, a Clinical Professor of Medicine, Yale University School of Medicine, the impact of COVID-19 on the GI system and GI disorders.
Host: Jacob Sands, MD
Cancer care has evolved since the initial outbreak of the COVID-19 pandemic. What do we need to know about caring for our cancer patients during this winter season? Dr. Jacob Sands, Thoracic Medical Oncologist at the Dana-Farber Institute in Boston shares what cancer patients can do to take care of themselves during the winter season.
Host: Hector O. Chapa, MD, FACOG
Guest: Robert Owens Carpenter, MD, MPH, FACS, FASMBS
Burnout is a common response to work overload in the field of medicine. What can we do to best avoid this? Dr. Hector Chapa joins Dr. Robert Owens Carpenter, the Texas A&M University College of Medicine’s Director of Wellness, to discuss the importance of managing mental health during the COVID-19 pandemic, not only for patients but healthcare professionals as well.
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Michael D. Kappelman, MD, MPH
Pediatric care has evolved amid the COVID-19 pandemic. And when it comes to treating inflammatory bowel disorder, or IBD, gastroenterologists are faced with a unique set of challenges. Join us as Dr. Kappelman shares highlights of his presentation at the 2021 Crohn’s & Colitis Congress on what needs to be acknowledged while treating children with IBD during the COVID-19 pandemic.
Host: Neilanjan Nandi, MD, FACP
The COVID-19 pandemic has presented a unique set of challenges for healthcare professionals. What are some of the biggest threats to our GI patients, and how should we help them stay safe? Here today is our GI Insights host, Dr. Neil Nandi, to shed some light on his experiences while caring for patients during the pandemic.
Host: John J. Russell, MD
Guest: Christopher Haines, MD, MA
The COVID-19 pandemic has altered the field of medicine. To better understand the science behind this virus while putting this pandemic into historical perspective, Dr. Christopher Haines shares his experiences caring for patients during the pandemic and describes what drove him to write his book: COVID-19 Essays from the Front: The First Six Months.
Guest: John J. Russell, MD
With so many COVID-19 vaccines in development, new medical ethical questions have been brought to the forefront of the healthcare field. With that in mind, Dr. John Russell takes us through the history of ethics and vaccinations throughout the world.
Published January 4, 2021
Host: Linda Bernstein, Pharm.D.
The U.S. Food and Drug Administration issued an emergency use authorization, or EUA, for the Moderna COVID-19 vaccine. The second vaccination to achieve EUA designation, the Moderna vaccine will be distributed throughout the US for patients 18 years and older. In this episode of The Drug Report, Dr. Linda Bernstein discusses this newly-approved vaccine and how it compares to others.
Published December 29, 2020
Host: Jacob Sands, MD
Guest: Nabil F. Saba, MD
Since head and neck cancer is still to a large extent a surgical disease, the COVID-19 pandemic had an immediate impact on its management. Here to share how he pivoted his approach and how the pandemic might impact the future of head and neck cancer care is Dr. Nabil Saba, a Professor and Vice Chair for Quality and Safety in the Department of Hematology and Medical Oncology at the Emory University School of Medicine.
Host: Jacob Sands, MD
Guest: Therese T. Bevers, MD
Fear of the COVID-19 pandemic has led to added safety precautions that have prevented patients from receiving much-needed cancer screenings. How will this impact the field of oncology, and what can we do to encourage patients to get their screenings? Dr. Therese Beavers, Medical Director of the Cancer Prevention Center at the University of Texas MD Anderson Cancer Center, joins Dr. Jacob Sands to discuss the fatal consequences of missed cancer screenings.
Host: Linda Bernstein, Pharm.D.
The first vaccine to receive Emergency Use Authorization from the US Food and Drug Administration, this authorization allows the Pfizer-BioNTech COVID-19 vaccine to be distributed throughout the US. But what do we know about this vaccine? In this episode of The Drug Report, Dr. Linda Bernstein discusses the Pfizer-BioNTech COVID-19 vaccine.
Published December 18, 2020
Host: Linda Bernstein, Pharm.D.
To prevent the flu from spreading concurrently with COVID-19, The U.S. Food and Drug Administration has expanded the approved indication for baloxavir marboxil to include post-exposure prevention of influenza. On this episode of The Drug Report, Dr. Linda Bernstein dives into this oral anti-influenza drug.
Published December 2, 2020
Host: Linda Bernstein, Pharm.D.
With the spread of the COVID-19 pandemic, fewer children have received a measles vaccination, and progress towards eliminating this disease has halted. How can pharmacists encourage more pediatric measles vaccinations? In this episode of The Drug Report, Dr. Linda Bernstein takes a look at the vast number of children globally who’ve yet to receive this vaccine.
Published November 30, 2020
Host: Linda Bernstein, Pharm.D.
In light of the COVID-19 pandemic, the Centers for Disease Control and Prevention, or the CDC, plans to use pharmacies to increase access to the COVID-19 vaccine when it is ready for distribution. In this episode of The Drug Report, Linda Bernstein will explain the CDC’s recently-developed Vaccination Program Interim Playbook.
Published November 17, 2020
Host: John E. Anderson, MD
Host: John Buse, MD, PhD
Host: Carol Wysham, MD
The outbreak of the COVID-19 pandemic has pushed healthcare professionals to adjust the way they treat patients with chronic conditions like diabetes. Tune in to hear Drs. John Anderson, John Buse, Carol Wysham share their experience caring for patients with diabetes amid the pandemic.
Host: Linda Bernstein, Pharm.D.
The Food and Drug Administration announced that Remdesivir is the first treatment for COVID-19 to receive their approval. To help us better understand this antiviral agent, Dr. Linda Bernstein discusses emerging studies uncovering the benefits and limitations of Remdesivir.
Published November 6, 2020
Guest: Lauren K. Brooks, MD
During this unprecedented time, finding the best approach to providing treatment for patients with thyroid cancer can be a challenge. Endocrinologist Dr. Lauren Brooks of Penn Medicine Lancaster General Health shares some of her approaches to this dilemma and stresses the importance of keeping up on routine practices during the COVID-19 pandemic.
Published September 28, 2020
Guest: Ann L. Steiner, MD
COVID-19 has encouraged many people to adopt new habits, but some of them can take a toll on a woman’s breast health. Tune in to hear Dr. Ann Steiner, Clinical Professor of Obstetrics and Gynecology at Penn Medicine, share what two of those risky habits are and how women can lower their risk of breast cancer while they’re sheltering at home.
Published September 23, 2020
Guest: Anil Agarwal, MD
How can healthcare professionals at the forefront of the pandemic protect the vascular integrity of COVID-19 patients undergoing acute dialysis procedures? Here to walk us through his process step by step is Dr. Anil Agarwal from the Ohio State University Wexner Medical Center.
Published August 19, 2020
Host: Matt Birnholz, MD
Guest: Anil Agarwal, MD
The emergence of blood clotting and clogged equipment for vascular procedures is a more recent—and troubling—phenomenon that’s emerged from the COVID-19 pandemic. Tune in as Dr. Anil Agarwal from the Ohio State University Wexner Medical Center discusses these two challenges and strategies for overcoming them.
Published August 13, 2020
Host: Andrew Wilner, MD, FACP, FAAN
Guest: William W. Li, MD
How do the lungs of healthy patients differ from the lungs of patients with COVID-19 or the flu? That’s the exact question Dr. William Li wanted to answer, and now, he’s sharing the results of his study that was recently published in the New England Journal of Medicine.
Published August 12, 2020
Host: Kathy King, RDN
Guest: Teresa Pangan, PhD, RDN
Joining Kathy King to discuss the possible benefits and precautions of using supplemental doses of vitamin D to help fight COVID-19 is Dr. Teresa Pangan, a registered dietitian, health counselor, and keynote speaker.
Host: Charles Turck, PharmD, BCPS, BCCCP
To find out how different racial and ethnic groups are being affected by the COVID-19 pandemic, Dr. Charles Turck joins us to analyze data that was collected by the COVID Racial Tracker.
Published July 24, 2020
Guest: Gregory J Kubicek, MD
When caring for patients who are at greater risk of complications from COVID-19, what extra precautions are needed to help keep them safe and healthy? That’s what staff radiation oncologist Dr. Gregory Kubicek from the MD Anderson Cooper Cancer Center shares with us.
Published June 23, 2020
Guest: Michael Greenberg, MD
The chaos and uncertainty brought on by the COVID-19 pandemic may make us forget the simple actions we can all do to connect with others and make the world a better place. Listen in as Dr. Michael Greenberg shares three of those simple actions.
Published June 15, 2020
Guest: Jennifer Shu, MD, FAAP
Tune in to hear Dr. Jennifer Shu describe what her life as a pediatrician is now like due to the COVID-19 pandemic and the steps she has taken to keep her patients and colleagues healthy.
Published June 12, 2020
Guest: Charles Turck, PharmD, BCPS, BCCCP
As researchers look at the spread of COVID-19 in warm areas of the globe, their findings cast doubt on the idea that the summer heat will help slow the spread. Tune in as Dr. Charles Turck explains recent studies on how heat has very little—if any—impact on the spread of viruses.
Published June 5, 2020
Host: Matt Birnholz, MD
Guest: Carol Vargo, MHS
Guest: Sheryl Hirsch, MD, FAAP
Guest: Thomas Eppes, MD
The American Medical Association is one of the leading medical organizations across the country that have been working to provide physicians with the tools and resources they need to continue caring for patients and to keep their practices financially afloat amid the COVID-19 pandemic. Joining Dr. Matt Birnholz to review the AMA’s guidance for reopening practices during the pandemic and how some practices have begun to reopen are Carol Vargo from the AMA, pediatrician Dr. Sheryl Hirsch, and family physician Dr. Thomas Eppes.
Guest: Charles Turck, PharmD, BCPS, BCCCP
With the growing amount of illicit pharmaceutical drugs and medical supplies filling the global market amid the COVID-19 pandemic, are we at risk of facing another public health crisis? Listen in as Dr. Charles Turck brings this troubling trend to light.
Published June 3, 2020
Host: Jennifer Caudle, DO
Guest: Todd Askew
What’s being done to address the range of issues like the PPE shortage, lack of testing, and financial shortfalls encountered during the COVID-19 pandemic? Here to share his team’s advocacy efforts to help tackle these and other challenges is Todd Askew, the American Medical Association's Senior Vice President of Advocacy.
Guest: John J. Russell, MD
Could immunization techniques of the past help us in our current hunt for a COVID-19 vaccine? To find out, Dr. John Russell reviews the history of immunizations going all the way back to the 1100s.
Published May 29, 2020
Host: Joshua Sharfstein, MD
Host: Stephanie Desmon
Guest: Albert Wu, MD
It’s been a few months since COVID-19 first arrived in the US, so what have we learned? Dr. Albert Wu returns to the podcast with Stephanie Desmon to discuss social distancing fatigue, new symptoms and disease observations, hopes for treatment, and what we should expect in the coming months in terms of a “return to normal.”
Published May 13, 2020
Host: Victor Test, MD, FCCP
Guest: Andrew Klein, MS, RT
Tune in as Andrew Klein, a clinical nurse specialist in respiratory therapy, discusses his experiences caring for COVID-19 patients in a teamwork environment. Through these collaborations, the best care can be made available during this pandemic.
Published March 26, 2020
Host: Joshua Sharfstein, MD
Guest: Megan Hosey Mastalerz, PhD
The intensive care unit can be stressful for all patients, but those with COVID-19 face unique challenges when it comes to mental and cognitive health. Clinical psychologist Dr. Megan Hosey of the Johns Hopkins Hospital ICU talks with Stephanie Desmon about ICU delirium, COVID-19 stigma, and what longer term prognosis could look like for patients inside and after the ICU.
Published May 6, 2020
Host: Mario R. Nacinovich, Jr., MSc
Guest: Mark R. Cullen, MD
Even before the COVID-19 pandemic hit, endemic challenges surrounded fragmented data sets and long perspective clinical trials. But now, recently developed data sets are available to public health and policy researchers to not only overcome that challenge, but also to combat this global pandemic. Dr. Mark Cullen, Scientific Committee Chair for the academic arm of the COVID-19 research database at Stanford University School of Medicine, joins Mario Nacinovich to explain.
Published May 13, 2020
Host: Matt Birnholz, MD
In the absence of a vaccine, researchers have reported the potential need for long-term social distancing measures through 2021. Tune in as Dr. Matt Birnholz breaks down these findings and what the potential impacts might be if these warnings are ignored.
Published May 11, 2020
Host: Joshua Sharfstein, MD
Guest: Emily S. Gurley, PhD
Guest: Brooke Jarrett
It might be too late to halt transmission of COVID-19, but contract tracing could help bring the outbreak under control. Dr. Emily Gurley and PhD candidate Brooke Jarrett break down contact tracing and what it would take to get “an army” off the ground in US cities.
Published April 29, 2020
Host: Mario R. Nacinovich, Jr., MSc
Guest: Renata Schiavo, PhD, MA
COVID-19 is constantly referred to as a global pandemic, but how often do you think of it as an info-demic? Or as a health equity issue? Joining Mario Nacinovich to give us a look at COVID-19 through a different lens is Dr. Renata Schiavo, Senior Lecturer, Columbia University Mailman School of Public Health, Department of Sociomedical Sciences and Founder and President of the Board of Directors of the Health Equity Initiative. Dr. Schiavo discusses common barriers faced by the most vulnerable populations and how we can protect them during and after the COVID-19 pandemic.
Published April 28, 2020
Host: Mario R. Nacinovich, Jr., MSc
Guest: Anthony Dragun, MD
Throughout this global pandemic, radiation oncologists are faced with the challenge of finding ways to continue administering the necessary cancer treatments while limiting their patients’ risk of exposure to COVID-19. Dr. Anthony Dragun from the MD Anderson Cancer Center is here to explain how that can be done and why these new approaches should be embraced even after the COVID-19 pandemic is over.
Published April 27, 2020
Host: Linda Bernstein, Pharm.D.
Join pharmacist Dr. Linda Bernstein as she highlights several articles from recent literature describing coagulopathies in severely ill COVID-19 patients in China. She explores the cause and effect theories behind these findings and whether the observed coagulopathies are due directly to the virus, the critically ill condition of the patient that predisposes them to thromboembolism, or some combination of the two.
Published April 24, 2020
Host: Joshua Sharfstein, MD
Guest: Beth Blauer
The COVID-19 dashboard run by the Johns Hopkins Center for Systems Science and Engineering has been a critical source of near real-time tracking of the spread of the novel coronavirus since it first emerged. Beth Blauer, Executive Director of Centers for Civic Impact and an expert on the public’s use of data and analytics, is part of the team that manages the map. Blauer talks to Dr. Josh Sharfstein about how the global dashboard originated, what new features have been added, and how the data can help individuals and officials make informed decisions for COVID-19 response.
Published April 14, 2020
Host: Linda Bernstein, Pharm.D.
Tune in as pharmacist Dr. Linda Bernstein looks at a few of the novel approaches researchers all over the world are taking to conquer the novel coronavirus in addition to evaluating what these approaches may mean for today and potential viral mutations going forward.
Published April 21, 2020
Host: Joshua Sharfstein, MD
Guest: Vernon Lee, PhD
Early on in the COVID-19 outbreak, Singapore quickly launched a robust response which included widespread testing, diligent contact tracing and quarantining, and isolation of all sick persons, even those with mild symptoms. Alumnus Dr. Vernon Lee, Director of Communicable Diseases at the Ministry of Health of Singapore, talks to Dr. Josh Sharfstein about how lessons from the 2003 SARS outbreak informed Singapore’s risk-based approach to staying a few steps ahead of the novel coronavirus.
Published April 7, 2020
Host: Linda Bernstein, Pharm.D.
This special episode of The Drug Report provides an update regarding the antiviral Remdesivir, which is the first investigational therapeutic to be studied under an FDA-approved NIH adaptive randomized controlled clinical trial for hospitalized COVID-19 patients. Currently, there are three options through clinical trials for obtaining remdesivir for the treatment of hospitalized patients with COVID-19 and pneumonia in the United States, as pharmacist Dr. Linda Bernstein explains.
Published April 10, 2020
Host: John J. Russell, MD
Guest: Diane E Custer, MD
As the COVID-19 pandemic continues to spread across our nation and the world, more and more patients are experiencing anxiety and depression. Joining Dr. John Russell to explain how we can console our patients—all while maintaining our own mental health along the way—is Dr. Diane Custer.
Published April 8, 2020
Host: Michael Greenberg, MD
To help alleviate pressure from hospitals that are experiencing a high influx of patients due to the COVID-19 pandemic, dermatologist Dr. Michael Greenberg decided to keep his doors open and is now sharing what it’s like to see patients during this outbreak.
Published April 3, 2020
Host: Matt Birnholz, MD
After the American College of Surgeons and the Surgeon General's suspension of non-emergent surgeries and procedures, Dr. Matt Birnholz explains the new guidelines and their impact on patients.
Published April 2, 2020
Host: Matt Birnholz, MD
In the absence of a vaccine or antivirals against COVID-19, controlling its transmission through social distancing has been an essential strategy. And to prove it, a team from the University of Western Australia conducted research using a simulation city which implemented social distancing versus a city without it. Dr. Matt Birnholz summarizes this study's staggering findings.
Published April 1, 2020
Host: John J. Russell, MD
Social distancing is surprisingly not a new concept in the United States. As our country geared up for World War I in 1918, social gatherings and parades to support the military were at an all-time high. But as feelings of patriotism spread at these events, so too did influenza. Join Dr. John Russell as he recounts The Tale of Two Cities: Philadelphia and St. Louis and how the spread of influenza was dramatically different between the two cities due to the actions each took to mitigate risk.
Published March 28, 2020
Host: Joshua Sharfstein, MD
Guest: Jennifer Nuzzo, MD
Guest: Tara Kirk Sell, PhD, MA
Guest: Lauren M. Sauer, MS
With COVID-19 beginning to spread via community transmission in the U.S. and the WHO raising its risk assessment to “very high,” experts from the Johns Hopkins School of Public Health and Johns Hopkins University School of Medicine offer insights on the growing global public health concern.
Featuring Dr. Jennifer Nuzzo and Dr. Tara Kirk Sell of the Johns Hopkins Center for Health Security and Lauren Sauer of the Johns Hopkins Office of Critical Event Preparedness and Response; moderated by Dr. Josh Sharfstein, Vice Dean of the Johns Hopkins Bloomberg School of Public Health and former secretary of Maryland's Department of Health.
Published March 3, 2020
Host: Matt Birnholz, MD
COVID-19 has irreversibly altered the progression track for the next generation of physicians, with cancellations of Match Day events, Board exams, and clinical rotations in effect. Now an increasing number of entities are calling on medical students to join front-line efforts to combat the virus.
Published March 23, 2020
Host: Mario R. Nacinovich, Jr., MSc
Guest: Charles P. Gerba, MD
The novel coronavirus outbreak that began in late 2019 may be the first global epidemic pronounced in the social media age, with myths and misinformation populating just as quickly and frequently as new cases. But is there any truth behind these claims? Here to shed light on this global health crisis is microbiologist Dr. Charles Gerba.
Host: Anne O'Donnell, MD
Guest: Patrick Flume, MD
Please note: This activity is no longer available for continuing education credit.
Nontuberculous mycobacteria lung disease (NTM-LD) is a relatively uncommon condition, although its prevalence is rising. In this interactive CME activity, Drs. Anne O’Donnell and Patrick Flume review two patient cases to demonstrate how clinicians can maintain a greater index of suspicion for the diagnosis of NTM-LD to enable timely and effective therapy. The management of NTM-LD remains challenging, owing to the need for long-term treatment, the potential for drug-related toxicities and patient nonadherence. These factors underscore the importance of specialty referral for the successful management of NTM-LD.
Host: Anne O'Donnell, MD
Guest: Robert "Brinkley" Sewell
Please note: This activity is no longer available for continuing education credit.
The successful management of nontuberculous mycobacteria lung disease (NTM-LD) remains challenging owing to the need for long-term treatment, the ongoing risks of adverse drug reactions, and the potential for nonadherence. These factors underscore the importance of specialty referral and shared decision making in the successful management of NTM-LD, as Dr. Anne O’Donnell and her patient Brinkley exemplify.
Guest: Mary Beth Pfeiffer
With cases being reported in every state and across 80 countries, Lyme disease has become one of the fastest growing vector-borne illnesses in the world. But have you ever wondered how this global health threat came to be? That’s what journalist Mary Beth Pfeiffer investigates in her book, Lyme: The First Epidemic of Climate Change, and with the ReachMD team.
Guest: Jennifer Caudle, DO
It’s an unfortunate reality that an increasing number of patients are refusing to get vaccinated—regardless of whether that’s the recommendation for themselves or their children. But luckily, there are ways you can talk to your patients about this, as Dr. Jennifer Caudle explains.
Host: Brian P. McDonough, MD, FAAFP
Guest: Jorge Garcia, MD
Even though people have gained immunity to the Zika virus in certain parts of the world, Zika outbreaks can—and do—still occur. Tune in as Dr. Jorge Garcia joins Dr. Brian McDonough to discuss the who, what, where, why, and how of the Zika virus, the once headline-dominating epidemic.
Host: Mario R. Nacinovich, Jr., MSc
Guest: Kalin Clifford, PharmD
Focusing on hospital-acquired and ventilator-associated pneumonia in older adults, Mario Nacinovich is joined by Dr. Kalin Clifford at the American Society of Consultant Pharmacists Annual Meeting. Together they dive deep into these two types of pneumonia to reveal new guidelines and the latest treatment options.
Host: Matt Birnholz, MD
Guest: Peng Zhang, PhD
Oxygen: It's the third most abundant element in our universe. From healthcare to industrial needs, we know oxygen's uses to be far-reaching, but could there still be more therapeutic potential yet?
In an in-depth conversation with Dr. Matt Birnholz, Dr. Pang Zheng presents new evidence of oxygen's potential uses within the healthcare industry.
Host: Jennifer Caudle, DO
August is National Immunization Awareness Month sponsored by the National Public Health Information Coalition. Dr. Jennifer Caudle discusses the important role immunizations play in healthcare.
Host: Brian P. McDonough, MD, FAAFP
Human papillomavirus (HPV) infection remains one of the most common sexually transmitted infections in both females and males, with about 9 in 10 people contracting HPV at some point in their lives.
Host Dr. Brian McDonough is joined by Samantha Gottlieb, medical anthropologist and author of Not Quite a Cancer Vaccine: Selling HPV and Cervical Cancer. They explore the history of Gardasil, a vaccine developed for HPV but marketed primarily as a cervical cancer vaccine, which became embroiled in sociopolitical debates about adolescent sexuality and pediatric vaccinations.
The two discuss these precedents alongside current controversies, such as whether vaccinating both males and females will induce herd immunity, and if the benefits outweigh the risks.
Host: Jennifer Caudle, DO
Guest: Lisa Ipp, MD
Although most college students in the U.S. believe it is important to get an annual influenza vaccine, less than half say they typically get vaccinated, according to results from a new National Foundation for Infectious Diseases (NFID) survey. Motivating college students to get their annual flu vaccinations remains a public health challenge that many health care officials have struggled to overcome.
Host Dr. Jennifer Caudle chats with Dr. Lisa Ipp about the results and takeaways from this survey and what methods and strategies would be the most effective in encouraging more students to get vaccinated.
Dr. Ipp is a Associate Professor of Clinical Pediatrics at Weill Cornell Medicine and Associate Director of Adolescent Medicine at New York-Presbyterian Komansky Children’s Hospital. She also serves as a board member for the National Foundation for Infectious Diseases (NFID)
Host: John J. Russell, MD
Guest: Meredith Wadman, BM, BCh, M.S.
Until the late 1960s, tens of thousands of American children suffered crippling birth defects if their mothers had been exposed to rubella, popularly known as German measles, while pregnant; there was no vaccine and little understanding of how the disease devastated fetuses.
In June 1962, a young biologist in Philadelphia, using human tissue samples sent from Sweden, produced a line of cells that allowed the creation of vaccines against rubella and other common childhood diseases. Two years later, in the midst of a massive German measles epidemic, the vaccine that would one day wipe out homegrown rubella was introduced. This vaccine has since protected more than 150 million people in the United States, and its development method has also led to other vaccines that have protected billions of people around the world from polio, rabies, chicken pox, measles, hepatitis A, shingles, and adenovirus.
Host Dr. John Russell chats with Meredith Wadman, author of The Vaccine Race: Science, Politics, and the Human Costs of Defeating Disease, about the story of both the science of this urgent race and the political and ethical controversies that nearly ended it prematurely.
Host: Matt Rosenberg, MD
Guest: Aiden Harrington, ANP, CNM
Current CDC Treatment Guidelines include transgender men and women as special populations. These guidelines recommend risk assessment based on current anatomy and sexual behaviors and screening for asymptomatic STIs based on the patient's history and sexual practices.
At a recent live event recorded in Chicago, moderator Dr. Matt T. Rosenberg welcomes Aiden Harrington, ANP, CNM from Howard Brown Health in Chicago, Illinois. Topics covered include health risks in the LGBTQ community, STI screening and treatment, and how to discuss sexuality with your patients.
Host: John J. Russell, MD
Do pets help prevent allergies? Does the 5-second rule actually exist? And is dirt really good for a child’s immune system?
Host Dr. John Russell talks with Jack Gilbert, Ph.D., Professor of Surgery at the University of Chicago and Director of the Microbiome Institute. Dr. Gilbert is author of the book Dirt is Good,answering questions about the potential benefits of exposure to germs and bacteria. He and Dr. Russell sift through common misconceptions about microbiomes to better understand their actual risks and benefits for the body's immune system, explaining its role in disease and health.
Host: Kathy King, RDN
Lyme disease is one of the most puzzling illnesses on the planet. Anyone who has suffered from its debilitating symptoms knows the frustrations of trying to find a cure.
Joining host Kathy King is Dr. Bill Rawls, physician and author of the book Unlocking Lyme: Myths, Truths and Practical Solutions for Chronic Lyme Disease. Dr. Rawls, who overcame Lyme disease himself, gives a comprehensive, practical review of clinical approaches.
Host: Jennifer Caudle, DO
Guest: Vincent Lo Re, MD, MSCE
In 2014, the CDC estimated a total of 2,194 cases of acute hepatitis across 40 states and estimates that 2.7-3.9 million people in the United States have chronic hepatitis C. Of every 100 persons affected by the disease, 75 to 85 will go on to develop chronic infection, 60 to 70 will go on to develop chronic liver disease, 5 to 20 will go on to develop cirrhosis over a period of 20–30 years, and 1 to 5 will die from the consequences of chronic infection (liver cancer or cirrhosis).
Joining our host, Dr. Jennifer Caudle, is Dr. Vincent Lo Re, Assistant Professor of Medicine and Infectious Diseases and Epidemiology at Penn Medicine. Dr. Lo Re discusses the current screening guidelines and recommendations regarding hepatitis C, long-term patient care, and the current landscape of treatment options.
Host: John J. Russell, MD
Infectious disease has the terrifying power to disrupt everyday life on a global scale, overwhelming public and private resources and bringing trade and transportation to a grinding halt.
Host Dr. John Russell sits down with Dr. Osterholm to talk about the book Deadliest Enemy: Our War Against Killer Germs. They talk about how we could wake up to a reality in which many antibiotics no longer cure, bioterror is a certainty, and the threat of a disastrous influenza pandemic looms ever larger. Only by understanding the challenges we face can we prevent the unthinkable from becoming the inevitable.
Host: John J. Russell, MD
After sitting at the feet of Martin Luther King at the University of Michigan in 1963, Larry Brilliant was swept up into the civil rights movement, marching and protesting across America and Europe. As a radical young doctor he followed the hippie trail from London over the Khyber Pass with his wife Girija, Wavy Gravy and the Hog Farm commune to India. There, he found himself in a Himalayan ashram wondering whether he had stumbled into a cult. Instead, one of India’s greatest spiritual teachers, Neem Karoli Baba, opened Larry’s heart and told him his destiny was to work for the World Health Organization to help eradicate killer smallpox. He would never have believed he would become a key player in eliminating a 10,000-year-old disease that killed more than half a billion people in the 20th century alone.
Host Dr. John Russell sits down with Dr. Larry Brilliant to discuss his book, Sometimes Brilliant and talk about his amazing journey from Detroit to counter-culture San Francisco to an ashram in India and beyond.
In this session of Beyond the Data carrying forward ideas discussed at CDC's Public Health Grand Rounds, Dr. Phoebe Thorpe speaks with Dr. Bobbi Pritt, Director of the Clinical Parasitology Laboratory and Co-Director of Vector-borne Diseases Laboratory Services at the Mayo Clinic. The two expand on Dr. Pritt's lecture focusing on advances in diagnosing tickborne diseases.
Host: John J. Russell, MD
Host Dr. Russell sits down with Dr. Steven Hatch, an infectious disease specialist and author of the book, Inferno: a Doctor's Ebola Story, about his experience in Liberia during the heart of the Ebola crisis.
Dr. Steven Hatch first came to Liberia in November 2013, to work at a hospital in Monrovia. Six months later, several of the physicians Dr. Hatch had mentored and served with were dead or barely clinging to life, and Ebola had become a world health emergency. Hundreds of victims perished each week; whole families were destroyed in a matter of days; so many died so quickly that the culturally taboo practice of cremation had to be instituted to dispose of the bodies. With little help from the international community and a population ravaged by disease and fear, the war-torn African nation was simply unprepared to deal with the catastrophe.
A physician’s memoir about the ravages of a terrible disease and the small hospital that fought to contain it, Inferno is also an explanation of the science and biology of Ebola: how it is transmitted and spreads with such ferocity. And as Dr. Hatch notes, while Ebola is temporarily under control, it will inevitably re-emerge―as will …
Host: Ana Maria Rosario
Guest: David Gandell, MD
Genital Herpes Simplex Virus (HSV) infection is a major public health problem. A dramatic upsurge in genital HSV infections have been documented from several prominent studies, making recognition, treatment, and patient counseling strategies more important than ever.
Joining host, Ana Rosario at the Women's Health Annual Visit in Deerborn, MI, is Dr. David Gandell, Clinical Professor of Obstetrics and Gynecology at the University of Rochester and attending phsyician at Strong Memorial Hospital.
Host: Jennifer Caudle, DO
News about the Zika virus have dominated health headlines, but understandings about the full range of viral transmission routes, symptomatology, complications, and rising endemic zones remain unclear for many clinicians.
Joining Dr. Jennifer Caudle for updates in recognitions and treatment for Zika virus infection is Dr. Kecia Gaither, practicing OB/GYN and maternal fetal medicine specialist, and perinatal consultant at St. Lukes Hospital in Kansas City, Missouri. Most recently, Dr. Gaither served as Director of Perinatal Outreach at Montefiore Medical Center and Albert Einstein College of Medicine. Prior to this post, she served as the Vice Chairman and Director of Maternal Fetal Medicine in the Department of Obstetrics & Gynecology at Brookdale University Hospital and Medical Center. Dr. Gaither earned her MPH in health policy and management at Columbia University.
Host: John J. Russell, MD
A fascinating and shocking historical exposé, The Malaria Project is the story of America's secret mission to combat malaria during World War II—a campaign modeled after a German project which tested experimental drugs on men gone mad from syphilis. Karen M. Masterson, a journalist turned malaria researcher, uncovers the complete story behind this dark tale of science, medicine and war.
Microbial colonization and lung function in adolescents with cystic fibrosis. Hector A, Kirn T, Ralhan A, Graepler-Mainka U, Berenbrinker S, Riethmueller J, Hogardt M, Wagner M, Pfleger A, Autenrieth I, Kappler M, Griese M, Eber E, Martus P, Hartl D. J Cyst Fibros. 2016 May;15(3):340-9. doi: 10.1016/j.jcf.2016.01.004. Epub 2016 Feb 5.
Abstract With intensified antibiotic therapy and longer survival, patients with cystic fibrosis (CF) are colonized with a more complex pattern ofbacteria and fungi. However, the clinical relevance of these emerging pathogens for lung function remains poorly defined. The aim ofthis study was to assess the association of bacterial and fungal colonization patterns with lung function in adolescent patients with CF. Microbial colonization patterns and lung function parameters were assessed in 770 adolescent European (German/Austrian) CF patients in a retrospective study (median follow-up time: 10years). Colonization with Pseudomonas aeruginosa and MRSA were most strongly associated with loss of lung function, while mainly colonization with Haemophilus influenzae was associated with preservedlung function. Aspergillus fumigatus was the only species that was associated with an increased risk for infection with P. aeruginosa.Microbial interaction analysis revealed three distinct microbial clusters within the longitudinal course of CF lung disease. …
Host: Jennifer Caudle, DO
Dr. Mary Guinan was one of the first scientists to conduct an initial investigation into the emerging HIV/AIDS epidemic for the Center for Disease Control and Prevention. Additionally, she was one of the first female physicians to work on smallpox eradication and has been a leading researcher and educator on sexually transmitted diseases.
Dr. Mary Guinan is the founding dean of the School of Community Health Sciences at the University of Nevada, Las Vegas, and is now a professor emerita.
She joins Dr. Jennifer Caudle to discuss her book, Adventures of a Female Medical Detective which explores Dr. Guinan's life in medicine, including her many experiences with emerging disease outbreaks and the efforts to control them. She provides a unique female perspective from a time when very few women worked in the field.
Host: Matt Birnholz, MD
Meningitis is one of the most feared manifestations of infectious disease for the medical community. Yet in spite of this fact, there are very few educational or advocacy-based resources dedicated to increasing public and professional awareness for meningococcal disease and updated prevention methods.
Dr. Matt Birnholz talks with Lynn Bozof, cofounder and President of the National Meningitis Association, an organization fully dedicated to meningitis education and prevention. They discuss her family’s tragic experience with the deadly disease, the preventive mission that originated from this loss, and ongoing efforts to educate clinicians and patients on the need for vaccinations and boosters.
Host: John J. Russell, MD
In recent years, malaria has emerged as a cause celebre for voguish philanthropists. Bill Gates, Bono, and Laura Bush are only a few of the personalities who have lent their names--and opened their pocketbooks--in hopes of stopping the disease. Still, in a time when every emergent disease inspires waves of panic, why aren't we doing more to tame one of our oldest foes? And how does a pathogen that we've known how to prevent for more than a century still infect 500 million people every year, killing nearly one million of them?
In The Fever, journalist Sonia Shah sets out to answer those questions, delivering a timely, inquisitive chronicle of the illness and its influence on human lives. Dr. John Russell hosts this fascinating discussion about her book.
Host: Matt Birnholz, MD
In the ongoing global campaign to prevent, treat, and cure HIV and AIDS, there have been countless therapeutic approaches targeting the HIV virus and everything it interacts with on the path to infection. But after decades of relentless infectivity claiming over 25 million lives, what if we could one day simply edit and delete the HIV virus right out of existence?
Joining Dr. Matt Birnholz to discuss a novel research effort to leverage gene editing technology in the fight against HIV is Dr. Kamel Khalili, Professor and Chair of the Department of Neuroscience, Director of the Center for Neuro-virology, and Director of the Comprehensive Neuro-AIDS Center at the Lewis Katz School of Medicine at Temple University.
[Read the Article]
Recent outbreaks of vaccine-preventable diseases in the United States have prompted clinicians, public health officials and the public to pay closer attention to the growing phenomenon of vaccine refusal. A new study looks at the role of vaccine refusal and the risk of measles and pertussis. In recent years, a substantial proportion of US measles cases occurred in people who were intentionally unvaccinated. Vaccine refusal was also found to be associated with an increased risk of pertussis in some populations.
[Watch more videos of The JAMA Report]
Host: John J. Russell, MD
Over the past fifty years, more than three hundred infectious diseases have either newly emerged or reemerged, appearing in territories where they’ve never been seen before. Ninety percent of epidemiologists expect that one of them will cause a deadly pandemic sometime in the next two generations. But which one, and how?
In Pandemic: Tracking Contagions, from Cholera to Ebola and Beyond, prizewinning journalist Sonia Shah interweaves history, original reportage, and personal narrative to explore the origins of contagions, drawing parallels between cholera, one of history’s most deadly and disruptive pandemic-causing pathogens, and the new diseases that stalk humankind today.
Guest: Anthony S. Fauci, MD
This week on Conversations on Health Care, hosts Mark Masselli and Margaret Flinter speak with Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health. Dr. Fauci is world renowned for his work battling HIV/AIDS and discusses the current efforts at NIAID, along with other global agencies, to contain and control the Zika pandemic.